TY  - JOUR
AU  - Sanabria-de la Torre, Raquel
AU  - Quiñones-Vico, María I
AU  - Fernández-González, Ana
AU  - Sánchez-Díaz, Manuel
AU  - Montero-Vílchez, Trinidad
AU  - Sierra-Sánchez, Álvaro
AU  - Arias-Santiago, Salvador
PY  - 2021
DO  - 10.3390/jcm10132991
SN  - 2077-0383
UR  - http://hdl.handle.net/10668/18221
T2  - Journal of clinical medicine
AB  - The well-known immunomodulatory and regenerative properties of mesenchymal stromal cells (MSCs) are the reason why they are being used for the treatment of many diseases. Because they are considered hypoimmunogenic, MSCs treatments are performed...
LA  - en
KW  - adverse events
KW  - alloantibodies
KW  - clinical trials
KW  - donor specific antibodies
KW  - immunogenicity
KW  - mesenchymal stromal cells
KW  - safety
TI  - Alloreactive Immune Response Associated to Human Mesenchymal Stromal Cells Treatment: A Systematic Review.
TY  - research article
VL  - 10
ER  -